Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Reported at similar rates for all three medications
It may be appropriate for researchers studying metabolic effects in subjects who are sensitive to gastrointestinal side effects or who have lower baseline body weight
Javitt DC, Liederman E, Cienfuegos A, Shelley AM (1999)
We review your bloodwork to ensure you are a candidate for the medications and develop a customized treatment plan for you
Lillys Phase 3 TRIUMPH-2 and TRIUMPH-3 trials show investigational retatrutide achieved up to 22.6% weight loss, supporting a planned FDA BLA in Q1 2027
Prescription GLP-1 receptor agonists (for example semaglutide (injectable) and tirzepatide (injectable)) are formulated to activate receptors strongly and for long durations
US$ 24.45
US$ 20.90
US$ 29.96
US$ 28.48
US$ 28.27
